BASHH 2012 UK Re-Audit of Asymptomatic Screening Dr Hugo McClean 1.

Slides:



Advertisements
Similar presentations
Sexually transmitted infections: epidemiological evidence of need Dr Kirsty Foster Consultant in Health Protection Public Health England Centre, North.
Advertisements

Recommendations for STD Clinical Preventive Services for Persons Living with HIV/AIDS.
BASHH 2009 Asymptomatic Screening Audit in UK GUM Clinics
An introduction to sexual health screening for Health Care Assistants
BASHH 2008 National Audit of Sexual History Taking Case Notes Audit (detailed data)
Annie Emery Acting Director of Business Development The Lesbian & Gay Foundation Are You Ready For Your Screen Test?
Antimicrobial Resistance in N. gonorrhoeae – An Overview 2014 INTRODUCTION Progressive antimicrobial resistance in Neisseria gonorrhoeae is an emerging.
Hugo McClean, Chair BASHH National Audit Group. Background to HQIP NCAPOP audits Current BASHH/MedFASH & BHIVA proposals Development to support new joint.
Epidemiology of Chlamydia in the United States Debra J. Mosure, Ph.D. Division of STD Prevention Centers for Disease Control and Prevention March 8, 2004.
Community HIV testing for men who have sex with men (MSM) Will it decrease undiagnosed infection? Jonathan Roberts Liaison Health Adviser Brighton & Sussex.
Region I Advisory Board Meeting Wells Beach, ME June 9, 2008 Use and Verification of STD Nucleic Acid Amplification Tests for non-FDA Cleared Clinical.
Gonococcal Isolate Surveillance Project (GISP)
Chlamydia trachomatis testing Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Chlamydia trachomatis? Chlamydia.
National Audit Group UK National Audit of Chlamydial Infection Management National Audit Group British Association for Sexual Health & HIV.
BASHH 09 Asymptomatic Screening Audit Case Notes Audit.
Sexually Transmitted Infections: UK National Screening and Testing Guidelines BASHH Guidelines 2006 Dr Olwen Williams.
2013 J OINT B ASHH & B HIVA N ATIONAL A UDIT OF P ARTNER N OTIFICATION OF A DULTS N EWLY D IAGNOSED WITH HIV INFECTION __________________________________.
Faiza Ali MD, Ericka Hayes MD, Gaurav Kaushik MPH, Nicole Carr RN, Katie Plax MD Washington University School Of Medicine Department of Pediatrics.
National Audit Group National Audit of Sexual Healthcare for People with HIV Infection National Audit Group British Association for Sexual Health & HIV.
Region I Laboratory Update CDC National Infertility Prevention Project Boston, Massachusetts November 15, 2010 Richard Steece, Ph.D., D(ABMM) Laboratory.
Slide 1 of Audit against the Key Performance Indicators (KPIs) in the BASHH MedFASH STI Management Standards (STIMS) Updated presentation 20 Sept.
STDs among Men who Have Sex with Men (MSM), San Francisco 2007—2010 STD Prevention and Control Services San Francisco Department of Public Health.
The Impact of Introducing “Express Visits” for Asymptomatic Persons Seeking STD Services in a Busy Urban STD Clinic System, Borrelli J 1, Paneth-Pollak.
Connecting BASHH National Audits to Local Audit and Practitioner Re-certification Hugo McClean Secretary BASHH National Audit Group.
Quality Measurement and Gender Differences in Managed Care Populations with Chronic Diseases Ann F. Chou Carol Weisman Arlene Bierman Sarah Hudson Scholle.
Expedited Partner Therapy The Denver Experience Cornelis A. Rietmeijer, MD, PhD Denver Public Health Department National Coalition of STD Directors Phoenix,
Region II IPP Data & Infrastructure Performance Measures Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
2010 BASHH NATIONAL RE-AUDIT ON SEXUAL HISTORY TAKING A Sullivan, H McClean, C Carne, S Tayal, D Daniels September 2010.
Networking Women in the Fire Service Who We Are and What We Do Karen Elliott East of England Regional Representative Suffolk, Norfolk, Essex, Cambridgeshire,
Evaluation of Presumptive Treatment Recommendation for Asymptomatic Anorectal Gonorrhoea and Chlamydia Infections in At-Risk Kenyan MSM IAS 24 July 2012.
Sexually Transmitted Disease Surveillance 2013 Division of STD Prevention.
Annual epidemiological spotlight on STIs in the South East: 2014 data Field Epidemiology Services, South East and London PHE gateway number:
Audit of outcomes in HIV BHIVA Audit and Standards Sub-Committee E Ong (chair), J Anderson, D Churchill, M Desai, S Edwards, S Ellis, A Freedman, P Gupta,
Infectious Syphilis in England: Changing epidemiology and new prevention needs Dr Kevin Fenton Consultant Epidemiologist HIV/STI Division PHLS Communicable.
22 February 2016 GRASP (Gonococcal Resistance to Antimicrobials Surveillance Programme) Catherine Ison Sexually Transmitted Bacteria Reference Laboratory.
Working Women: Are they getting enough? Julie Ledger Health Adviser Withington Hospital. Manchester.
Inequalities in Sexual Health. Update on HIV and STIs in men who have sex with men in London Field Epidemiology Services PHE Publications gateway number:
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
Teenage conceptions: progress Anglia and Essex 2Teenage conceptions: progress Percentage change in under 18 conception rate
STI Management- When to refer? Dr Vendela McNamara Leicester Sexual Health Service.
The Dublin Well Woman Centre and The National Virus Reference Laboratory  Approved by ICGP Ethics Committee.
Rodney C. Perkins 1, Grace K. Douglass 2, Victoria C. Ta 2, Aurnell Dright 1, Michael Fomundam 2, Ying Li 3, Michael Plankey 3 Sexually Transmitted Infection.
Expanded PrEP implementation in NSW (EPIC-NSW) 1 AIDS 2016 | 22 July 2016.
Hitting the bull’s-eye: Partner Notification real-time metrics BASHH Annual Conference Oxford, 10th July 2016 Dr Anatole S Menon-Johansson & Leigh Barlow.
Six years of outreach testing –is it working? Dr Carol Emerson Belfast Trust.
Annual Epidemiological Spotlight on STIs in London: 2015 data Field Epidemiology Services PHE publications gateway number:
Triage review: Should they stay, or should they go? Dr Susanna Currie ST4 Genitourinary Medicine Central Manchester University Hospitals NHS Foundation.
R ATES OF A SYMPTOMATIC L YMPHOGRANULOMA V ENEREUM IN MEN WHO HAVE SEX WITH MEN Tristan Griffiths Neesha Rockwood Nneka Nwokolo 56 Dean Street, Chelsea.
BASHH Conference, Oxford 2016
What’s New in STI Testing?
Dr Andrew Leung Bristol Sexual Health Centre
Seeking HIV-testing Only: Missed Opportunity for HIV Prevention?
Extra-genital samples for gonorrhoea and chlamydia in women and MSM Self-taken samples analysed separately compared with self-taken pooled samples Janet.
Rectal chlamydia infection in women Have we been missing the point?
BACKGROUND ODC/402/18/6/QA_QAF+Toolkit overview for launch v1.
An Update from the Local Authority Commissioners
Non-specific Urethritis: Can we be a bit more specific?
Gonococcal Isolate Surveillance Project (GISP)
Sexually Transmitted Infections (STIs) in Ireland: Q1-Q2, 2017
HPV vaccination for men
Sexually Transmitted Infections (STIs) in Ireland: 2017
Website Information Website Information
Health Protection Surveillance Centre
Understanding the increase in gonorrhoea diagnoses from GUM clinics (Northern Ireland) S Todd 1, S McGuinness 2, N Irvine 2, S Quah 1 1 Public Health.
Sexually Transmitted Infections (STIs) in Ireland, 2016
PEPSE* PRESCRIPTION IN THE EMERGENCY DEPARTMENT
Health Protection Surveillance Centre
Sexually transmitted infections – trends and challenges
Nucleic Acid Amplification Tests for the Diagnosis of Chlamydia trachomatis Rectal Infections Bachmann LH1,2, Johnson R3, Cheng H1, Markowitz L3, Papp.
Presentation transcript:

BASHH 2012 UK Re-Audit of Asymptomatic Screening Dr Hugo McClean 1

BASHH 2012 Audit standards Sexually Transmitted Infections: UK National Screening and Testing Guidelines August Recommended Tests for Asymptomatic Patients This presentation builds upon the recommendations from the 2009 audit

BASHH 2012 Audit- presentation scheme Standards Methods Results Key messages Recommendations for improvement

Conclusions 2009 Audit High overall rates of testing with BASHH CEG first line recommended tests for chlamydia, syphilis and HIV High overall rates of testing for gonorrhoea in women when NAATs included Important number of cases having N. gonorrhoeae NAATs, including urine GC NAATs (45% MSM) Urethral microscopy ~ 20% men Cervical microscopy ~ 10% Most MSM tested for HepB (80%) Predominance of hepatitis C testing in MSM

Suggested Areas for Practice Improvement/Interventions 2009 Audit Increased documentation of discussion about oral and anal sex, as recommended in the BASHH recommendations on sexual history taking to identify which anatomical sites need to be sampled for infection Regional strategies should be considered to balance nucleic acid amplification testing for gonorrhoea with culture testing to monitor antibiotic sensitivity Increased screening for hepatitis B in MSM is needed in some regions. Increased screening for HIV is needed in some regions, particularly for women

Standards 6

Asymptomatic heterosexual men *Urethral culture only for gonorrhoea: 1194 (58%, 2-98%) **Recommended if urethral specimen not available

Asymptomatic MSM *Urethral culture only for gonorrhoea **Recommended if urethral specimen not available

Asymptomatic women * recommended if urethral specimen not available

Case definition No symptoms offered on presentation (either on a triage form, or similar form, or on direct questioning by a healthcare worker) Seen during a first meeting in a new or re- book episode

Data collection- 1 Audit interval: – Clinic policies: on day of audit – Cases seen 1 October to 31 December 2011 Data collection – Launched 7 Jan 2012 – Closed 15 April 2012 Participation: – Level 3 services: BASHH NAG Regional Chairs network – BASHH website, s, BASHH Newsletter

Data collection- 2 Data submitted using an online form Clinic policy data Case note data: – Up to consecutive 40 cases* *RCP Local Clinical Audit: handbook for physicians: standards/ceeu/Documents/Local-clinical-audit-handbook-for-physicians-August-2010.pdfhttp://old.rcplondon.ac.uk/clinical- standards/ceeu/Documents/Local-clinical-audit-handbook-for-physicians-August-2010.pdf

Results Case, clinic, regional and national level data National aggregate composed of regional-level data Percentage of clinics in each BASHH Region meeting performance levels Overall national performance

Questions asked 1.Recording of oral sex: occurrence, non- occurrence, patient declined to answer, documented not asked, no record, not applicable 2.Receptive anal sex: same as for oral sex 3.Offer of HIV testing: offered & done, offered & declined, not offered, not applicable 4.Tests for hepatitis B, or immune or chronic infection or not appliacable 5.Tests for gonorrhoea 14

Gender and sexual preference Total 6669 cases – Women: 3321 (50%) – Men: 3348 (50%) Het men: 3020 (90%) MSM: 328 (10%) 15

Number (%) of clinics participating, by Region BranchNumber of cases submitted North Thames804 South East Thames602 South West511 West Midlands499 Wales487 Northern447 Yorkshire443 Anglia408 South West Thames398 North West384 Trent361 Oxford279 Wessex279 Northern Ireland205 Essex204 Cheshire and Merseyside196 Scotland162 National6669

Documentation about oral sex 17

Documentation about receptive oral sex- women 18 Percentage of cases having a record made about occurrence or non-occurrence of receptive oral sex 2009: 45% (8-65%)

Documentation about receptive oral sex- het men 19 Percentage of cases having a record made about occurrence or non-occurrence of receptive oral sex

Documentation about receptive oral sex- MSM 20 Percentage of cases having a record made about occurrence or non-occurrence of receptive oral sex 2009: 81% (50-100%)

Documentation about anal sex 21

Documentation about receptive anal sex- women 22 Percentage of cases having a record made about occurrence or non-occurrence of receptive anal sex

Documentation about receptive anal sex- MSM 23 Percentage of cases having a record made about occurrence or non-occurrence of receptive anal sex

Recording of occurrence of anal sex in heterosexual men- national data 24 Region Anal sex recorded as ‘occurred’ Anglia n=1930.5% Cheshire and Merseyside n=850.0% Essex n=940.0% North Thames n=3390.3% North West n=1620.0% Northern n=2054.4% Northern Ireland n=990.0% Oxford n=1281.6% Scotland n=681.5% South East Thames n=2771.1% South West n=2385.5% South West Thames n=1680.6% Trent n=1810.0% Wales n=2350.9% Wessex n=1260.0% Yorkshire n=1960.0% West Midlands n=2261.3% National, N= %

HIV testing uptake 25

HIV testing uptake- eligible MSM 26 Percentage of eligible MSM having an HIV test (‘not applicable’ excluded)

HIV testing uptake- eligible women 27 Percentage of eligible women having an HIV test (‘not applicable’ excluded)

HIV testing uptake- eligible het men 28 Percentage of eligible het men having an HIV test (‘not applicable’ excluded)

Hepatitis B testing uptake 29

Hepatitis B testing uptake- eligible MSM 30 Percentage of eligible MSM having a test for hepatitis B (‘not applicable,’ ‘immune,’ ‘chronic infection ’ all excluded)

Hepatitis B testing uptake- eligible women 31 Percentage of eligible women having a test for hepatitis B (‘not applicable,’ ‘immune,’ ‘chronic infection ’ all excluded)

Hepatitis B testing uptake- eligible het men 32 Percentage of eligible men having a test for hepatitis B (‘not applicable,’ ‘immune,’ ‘chronic infection ’ all excluded)

Gonorrhoea testing 33

Gonorrhoea testing- MSM, any test done 34 Percentage of MSM having any test done for gonorrhoea

Gonorrhoea testing- women, any test done 35 Percentage of women having any test done for gonorrhoea

Gonorrhoea testing- het men, any test done 36 Percentage of het men having any test done for gonorrhoea 2009: 96% (89-100%)

Gonorrhoea testing- women, tests done (not oropharyngeal NAAT & culture) 37 Anatomical site/test Number 2012 (%, regional range %) N=3321 Number 2009 (%, regional range %) N=2131 Cervical culture1310 (39%, 0-83%)1393 (65%, 26-94%) Vulvovaginal NAAT1289 (39%, 0-81%)244 (12%, 0-29%) Urethral culture872 (26%, 0-71%)953 (45%, 16-82%) Cervical NAAT656 (20%,1-55%)250 (12%, 0-44%) Vulvovaginal culture195 (6%, 0-34%)- Urine NAAT181 (6%, 0-16%)209 (10%,0-36%) Urethral microscopy130 (4%,0 -13%)(%,-%) Urethral NAAT45 (1%, 0-16%)33 (2%, 0-13%) Cervical microscopy7 (0.2%, 0-27%)248 (12 %,0-42%) Rectal microscopy15 (0.2%, 0-1.1%)

Gonorrhoea testing- women, tests done: oropharyngeal & rectal NAAT & culture 38 Anatomical site/testNumber (%, regional range % Oropharyngeal culture (all women, N=3321)151 (5%, 0-16%)  Receptive oral sex occurred, n= (11%, 0-44%) Oropharyngeal NAAT (all women, N=3321)102 (3%, 0-24%)  Receptive oral sex occurred, n= (8%, 0-39%) Rectal culture (all women, N=3321)40 (1%, 0-7%)  Receptive anal sex occurred, n=17719 (11%, 0-50%) Rectal NAAT (all women, N=3321)28 (1%, 0-4%)  Receptive anal sex occurred, n=17722 (12%, 0-100%)

2009 Audit. Asymptomatic women: oropharyngeal & rectal gonorrhoea culture

Gonorrhoea testing- MSM, tests done (not oropharyngeal NAAT & culture) 40 Anatomical site/test Number 2012 (%, regional range %) N=328 Number 2009 (%, regional range %) N=219 Urine NAAT228 (70%, 0-100%)98 (45%, 0-100%) Urethral culture 114 (35%, 9-100%)119 (54%, 9-100%) Urethral microscopy 35 (11%, 0-44%)38 (17%, 0-100%) Rectal microscopy 16 (5%, 0-44%)9 (4%, 0-25%) Urethral NAAT 8 (2%, 0-46%)7 (3%, 0-20%)

Gonorrhoea testing- MSM, tests done: oropharyngeal & rectal NAAT & culture 41 Anatomical site/testNumber (%, regional range %) Oropharyngeal NAAT (all MSM, N=328)164 (50%, 0-92%)  Receptive oral sex occurred, n= (54%, 0-92%) Oropharyngeal culture (all MSM, N=328)170 (52%, 0-83%)  Receptive oral sex occurred, n= (54%, 0-91%) Rectal NAAT (all MSM, N=328)163 (50%, 0-89%)  Receptive anal sex occurred, n= (59%, 0-100%) Rectal culture (all MSM, N=328)136 (42%, 11-89%)  Receptive anal sex occurred, n= (53%, 0-100%)

2009 Audit. Asymptomatic MSM: oropharyngeal & rectal

Gonorrhoea testing- het men, tests done Anatomical site/testNumber 2012 (%, regional range %) N= 3020 Number 2009 (%, regional range %) N= 2078 Urine NAAT 2017 (67%, 17-99%)751 (36%, 0-100%) Urethral culture 972 (32%, 0-85%)1194 (58%, 2-98%) Urethral microscopy 306 (10%, 0-22%)459 (22%, 0-87%) Urethral NAAT53 (2%, 0-10%)84 (4%, 0-16%) Oropharyngeal culture 60 (2%, 0-8%)38 (2%, 0-8%) Oropharyngeal NAAT 23 (1%, 0-6%)3 (0.1%, 0-2%) Rectal culture 3 (0.1%, 0-1%)0 Rectal NAAT 6(0.2%, 0-1%)0 Rectal microscopy00

Key points 44 Why do we ask fewer women than men about peno-oral sex? Lack of documentation about receptive oral sex in MSM some regions Should we ask ‘het men’ about receptive anal sex? Half of female patients asked about receptive anal sex and, even when this occurred, relatively few had rectal Gc testing. Similarly, for receptive oral sex Why do fewer women (still) have an HIV test? Testing women for gonorrhoea: cervical NAAT or vulvovaginal NAAT?

Recommendations for improvement Review policies for gonorrhoea testing, particularly in women, and re-audit interventions aimed at improving uptake of testing Consensus on sexual history taking questions, reflected in training Consensus on anatomical site for NAAT testing, reflected in training 45

Acknowledgements: BASHH Regional Audit Chairs & Members Chair Hugo McClean Vice Chair Chris Carne Hon Sec Ann Sullivan Director of Development Anatole Menon- Johansson BCCG Representative Phil Kell BHIVA Representative Alison Rodger, Ed Wilkins Scotland Daniel Clutterbuck Wales Helen Baley, Sarah McAndrew, Carys Knapper Northern Ireland Say Quah Anglia Raouf Moussa Cheshire & Mersey Ravindra Gokhale Essex Gail Crowe North Thames Ann Sullivan, Alan Smith Northern Sarup Tayal North-West Ashish Sukthankar Oxford Gill Wildman South East Thames Cindy Sethi South-West Zoe Warwick South-West Thames Steven Estreich Trent Jyoti Dhar Wessex Neelam Radja, Leela Sanmani West Midlands Sashi Acharya Yorkshire Amy Tobin-Mammen Co-opted Members David Daniels, Nicola Low, Lindsay Emmett Hilary Curtis for questionnaire design, collection, collation of data, user support and production of regional & national aggregates